Emerging treatment strategies for Richter’s transformation in CLL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-03-10
Просмотров: 36
Описание:
Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, discusses emerging treatment strategies for Richter's transformation, highlighting promising results from the Phase II CLL-RT1 trial (NCT04271956) evaluating tislelizumab in combination with zanubrutinib. She also outlines the need for combination approaches and future options including CAR T-cell therapy and bispecific antibodies. This interview took place at the ESH CLL 2026 congress in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
